StonvexLoading…
StonvexStonvexStonvexCore line items from FA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $385.20M | $1.57B | $1.15B | $745.22M |
Operating Income | $33.52M | $132.47M | $87.60M | $45.35M |
Net Income | $2.17M | $-34.82M | $-38.29M | $308.00K |
EPS (Diluted) | $0.01 | $-0.20 | $-0.22 | $-0.24 |
Total Assets | $3.75B | $3.83B | $3.86B | $3.87B |
Total Liabilities | $2.46B | $2.52B | $2.55B | $2.57B |
Cash & Equivalents | $225.91M | $240.00M | $216.85M | $184.26M |
Free Cash Flow OCF − CapEx | $46.62M | $188.49M | $126.34M | $55.10M |
Shares Outstanding | 172.71M | 174.19M | 174.04M | 173.84M |